On May 20, 2024, a special day, the product manager and technician from an Indonesian company with a customer base of 2000 made a special trip to YZY Med to inspect the company’s tumor-targeted gene detection reagents for lung cancer.
The Indonesian customers visited our office building, laboratory, and two production factories. They learned in detail about the company’s four CE-certified product lines: PGX, CDX, CTC, and FISH. They personally witnessed the company’s R&D strength, quality, and capacity assurance system. They personally experienced the use of the EGFR gene detection reagent, answered many questions raised by their customers, and highly praised YZY’s technology and services. After conducting market research on other potential cooperation product lines, they will discuss cooperation, such as introducing the CTC sorter into cancer hospitals.
This visit not only deepened the cooperation between the two parties, but also confirmed that YZY’s influence in the international market has further increased! We look forward to more cooperation results with Indonesian and even global customers, jointly promoting the development of precision medicine, and benefiting patients worldwide.
